Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | ABBV-101 |
Trade Name | |
Synonyms | ABBV 101|ABBV101 |
Drug Descriptions |
ABBV-101 is a selective BTK degrader, with activity against mutant BTK, which potentially inhibits tumor growth (Cancer Res (2024) 84 (6_Supplement): 605). |
DrugClasses | BTK inhibitor 37 |
CAS Registry Number | NA |
NCIT ID | C200056 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
ABBV-101 | ABBV-101 | 0 | 1 |